DigitalHealth.London Accelerator alumnus Skin Analytics has partnered with Bupa to provide their new home service to support remote skin cancer assessment.
Bupa customers are sent an imaging kit, which includes a smartphone and a magnifying scope to take pictures of suspicious moles or marks. The images are then sent to dermatologists to review within 24 hours.
Bupa customers can call the Bupa Cancer Direct Access service, and if suitable, the next working day will receive a kit.
Alex Perry, CEO, Bupa UK Insurance said: “The biggest thing that makes the difference in cancer treatment is detecting and treating it early. Worryingly, at the height of the crisis fewer people were coming forward with signs and symptoms that might be cancer.”
“Our remote skin assessment and Cancer Direct Access services help to remove any potential barriers, reducing the time between detection, diagnosis and treatment.”
Neil Daly, CEO Skin Analytics said, “We’re delighted to be working with Bupa to help improve patient access to skin cancer assessments. The adoption of clinically validated AI is opening up new ways of delivering care and we’re excited to extend this to Bupa’s members. This builds on existing services and our NHS launch with University Hospitals Birmingham in April to make Skin Analytics available to more than 5 million patients across the UK. We’re delighted to have been guided on this journey by the Digital Health London Accelerator.”
You might also be interested in: Skin Analytics: Skin cancer detection during COVID-19